Begonia Ho
About Begonia Ho
Begonia Ho serves as the Head of Scientific Affairs at Cronos Group, where she has worked since 2020. With a Ph.D. in Pharmacology from the University of Minnesota, she has extensive experience in drug discovery, research and development, and regulatory compliance across several companies.
Current Role at Cronos Group
Begonia Ho serves as the Head of Scientific Affairs at Cronos Group, a position she has held since 2020. In this role, she oversees scientific initiatives and strategies within the organization, focusing on the development and compliance of cannabinoid products. Her responsibilities include ensuring that product claims meet FDA and FTC regulations, as well as coaching cross-functional teams in science-based product development.
Previous Experience at Melaleuca
Before joining Cronos Group, Begonia Ho worked at Melaleuca: The Wellness Company as the Senior Director of Research and Development from 2014 to 2020. During her tenure, she led research initiatives and contributed to the development of wellness products, enhancing the company's product portfolio through scientific innovation.
Professional Background in Drug Discovery
Begonia Ho has a solid background in drug discovery, having worked as a Principal Investigator at Serono Inc from 2000 to 2001. Her role involved leading research projects in Boston, MA, focusing on the development of new therapeutic agents. Additionally, she held various positions in clinical development and regulatory affairs, including a fellowship at Kendle International.
Education and Expertise in Pharmacology
Begonia Ho earned her Ph.D. in Pharmacology from the University of Minnesota Medical School, where she studied from 1984 to 1989. Her educational background provides her with a strong foundation in pharmacological principles, which she applies in her current and previous roles in the pharmaceutical and wellness industries.
Experience at Procter and Gamble
From 2002 to 2014, Begonia Ho worked at Procter and Gamble as Section Head of Health Care. In this capacity, she was responsible for overseeing health care product development and ensuring that products met regulatory standards. Her leadership in this role contributed to the advancement of health-related consumer products.